Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$12.3 - $35.76 $1.11 Million - $3.22 Million
-90,100 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$20.77 - $42.37 $884,802 - $1.8 Million
42,600 Added 89.68%
90,100 $3.5 Million
Q3 2018

Nov 14, 2018

BUY
$41.2 - $59.85 $103,000 - $149,625
2,500 Added 5.56%
47,500 $2.18 Million
Q2 2018

Aug 14, 2018

BUY
$48.3 - $68.25 $2.17 Million - $3.07 Million
45,000 New
45,000 $2.66 Million

Others Institutions Holding PBYI

About PUMA BIOTECHNOLOGY, INC.


  • Ticker PBYI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,556,000
  • Market Cap $147M
  • Description
  • Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...
More about PBYI
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.